The level of HBXIP expression in NSCLC tissue was assessed by immunohistochemical and Western blot analyses, and its relationships with clinicopathological features and outcomes were statistically evaluated. The gene discussed is LAMTOR5; the disease is non-small cell lung carcinoma.